A detailed history of Proffitt & Goodson Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Proffitt & Goodson Inc holds 174 shares of MRK stock, worth $17,681. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174
Previous 197 11.68%
Holding current value
$17,681
Previous $24,000 20.83%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$111.15 - $128.97 $2,556 - $2,966
-23 Reduced 11.68%
174 $19,000
Q2 2024

Jul 23, 2024

BUY
$123.8 - $132.96 $24,388 - $26,193
197 New
197 $24,000
Q2 2022

Jul 25, 2022

SELL
$83.49 - $94.64 $20,872 - $23,660
-250 Closed
0 $0
Q1 2021

May 03, 2021

SELL
$68.86 - $81.11 $2,134 - $2,514
-31 Reduced 11.03%
250 $19,000
Q2 2020

Aug 05, 2020

BUY
$70.42 - $80.13 $17,605 - $20,032
250 Added 806.45%
281 $22,000
Q1 2019

Apr 18, 2019

BUY
$69.58 - $79.36 $2,156 - $2,460
31 New
31 $3,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Proffitt & Goodson Inc Portfolio

Follow Proffitt & Goodson Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Proffitt & Goodson Inc, based on Form 13F filings with the SEC.

News

Stay updated on Proffitt & Goodson Inc with notifications on news.